SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-17-000002
Filing Date
2017-01-18
Accepted
2017-01-18 16:03:56
Documents
19
Period of Report
2017-01-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kdecembermor_01182017.htm 8-K 35666
2 EXHIBIT 99 di282decembermor.htm EX-99 4993
3 di282decembermor001.jpg GRAPHIC 95773
4 di282decembermor002.jpg GRAPHIC 25822
5 di282decembermor003.jpg GRAPHIC 14388
6 di282decembermor004.jpg GRAPHIC 117819
7 di282decembermor005.jpg GRAPHIC 217398
8 di282decembermor006.jpg GRAPHIC 160043
9 di282decembermor007.jpg GRAPHIC 84695
10 di282decembermor008.jpg GRAPHIC 95718
11 di282decembermor009.jpg GRAPHIC 91625
12 di282decembermor010.jpg GRAPHIC 145532
13 di282decembermor011.jpg GRAPHIC 74105
14 di282decembermor012.jpg GRAPHIC 87352
15 di282decembermor013.jpg GRAPHIC 153622
16 di282decembermor014.jpg GRAPHIC 110372
17 di282decembermor015.jpg GRAPHIC 124846
18 di282decembermor016.jpg GRAPHIC 49793
19 di282decembermor017.jpg GRAPHIC 129986
  Complete submission text file 0001338095-17-000002.txt   2442964
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 17533491
SIC: 2834 Pharmaceutical Preparations